These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1555498)

  • 1. Paroven: not much effect in trials.
    Drug Ther Bull; 1992 Jan; 30(2):7-8. PubMed ID: 1555498
    [No Abstract]   [Full Text] [Related]  

  • 2. O-(beta-hydroxyethyl)-rutosides (Paroven; Venoruton): new studies, improved safety, and novel cardiovascular applications.
    Cesarone MR; Belcaro G; Grossi MG
    Angiology; 2008; 59 Suppl 1():5S-6S. PubMed ID: 18287161
    [No Abstract]   [Full Text] [Related]  

  • 3. [New aspects in the pathogenesis of chronic venous insufficiency and the place of localized action of Venoruton].
    Bekers S; Zilstra I
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():28-32. PubMed ID: 19705689
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
    Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
    Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroven in the treatment of chronic venous insufficiency.
    Pulvertaft TB
    Practitioner; 1979 Dec; 223(1338):838-41. PubMed ID: 396527
    [No Abstract]   [Full Text] [Related]  

  • 6. [Venoruton in chronic venous insufficiency].
    Golden GJ
    Ugeskr Laeger; 1993 Jan; 155(3):182-3. PubMed ID: 8421882
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.
    Perrin M; Ramelet AA
    Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):117-25. PubMed ID: 21126890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent].
    Cervantes A; Gorodovsky J; Peña A; Campos J
    Ginecol Obstet Mex; 1976 Aug; 40(238):113-6. PubMed ID: 786800
    [No Abstract]   [Full Text] [Related]  

  • 9. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
    Frick RW
    Angiology; 2000 Mar; 51(3):197-205. PubMed ID: 10744007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of Veliten (rutine, alpha-tocopherol and ascorbic acid) in patients with chronic venous insufficiency.
    Auteri A; Pasqui AL; Bruni F; Di Renzo M; Bova G; Chiarion C; Delchambre J
    Int J Clin Pharmacol Res; 1994; 14(3):95-100. PubMed ID: 7883390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
    Köstering H; Bandura B; Merten HA; Wieding JU
    Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the efficacy and tolerability of hydroxyethylrutosides for improvement of the signs and symptoms of chronic venous insufficiency.
    Aziz Z; Tang WL; Chong NJ; Tho LY
    J Clin Pharm Ther; 2015 Apr; 40(2):177-85. PubMed ID: 25630350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.
    Petruzzellis V; Troccoli T; Candiani C; Guarisco R; Lospalluti M; Belcaro G; Dugall M
    Angiology; 2002; 53(3):257-63. PubMed ID: 12025912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study.
    Cesarone MR; Belcaro G; Ippolito E; Pellegrini L; Ledda A; Luzzi R; Ricci A; Dugall M; Bavera P; Hosoi M; Stuard S; Corsi M
    Panminerva Med; 2010 Jun; 52(2 Suppl 1):43-8. PubMed ID: 20657534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
    Boisseau MR; Taccoen A; Garreau C; Vergnes C; Roudaut MF; Garreau-Gomez B
    J Cardiovasc Surg (Torino); 1995 Aug; 36(4):369-74. PubMed ID: 7593149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
    Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
    Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
    [No Abstract]   [Full Text] [Related]  

  • 17. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
    Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
    Rehn D; Unkauf M; Klein P; Jost V; Lücker PW
    Arzneimittelforschung; 1996 May; 46(5):483-7. PubMed ID: 8737631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
    Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
    Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
    Pulvertaft TB
    Vasa; 1983; 12(4):373-6. PubMed ID: 6362258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.